Literature DB >> 29604048

Peripherally induced regulatory T cells contribute to the control of autoimmune diabetes in the NOD mouse model.

Cornelia Schuster1, Franziska Jonas1, Fangzhu Zhao1, Stephan Kissler1.   

Abstract

Type 1 diabetes (T1D) results from the autoimmune destruction of pancreatic beta cells and is partly caused by deficiencies in the Foxp3+ regulatory T-cell (Treg) compartment. Conversely, therapies that increase Treg function can prevent autoimmune diabetes in animal models. The majority of Tregs develop in the thymus (tTregs), but a proportion of Foxp3+ Tregs is generated in the periphery (pTregs) from Foxp3- CD4+ T-cell precursors. Whether pTregs play a distinct role in T1D has not yet been explored. We report here that pTregs are a key modifier of disease in the nonobese diabetic (NOD) mouse model for T1D. We generated NOD mice deficient for the Foxp3 enhancer CNS1 involved in pTreg induction. We show that CNS1 knockout decreased the frequency of pTregs and increased the risk of diabetes. Our results show that pTregs fulfill an important non-redundant function in the prevention of beta cell autoimmunity that causes T1D.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CNS1; Foxp3; Type 1 diabetes; pTreg

Mesh:

Substances:

Year:  2018        PMID: 29604048      PMCID: PMC6033626          DOI: 10.1002/eji.201847498

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  30 in total

1.  MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells.

Authors:  Esen Sefik; Naama Geva-Zatorsky; Sungwhan Oh; Liza Konnikova; David Zemmour; Abigail Manson McGuire; Dalia Burzyn; Adriana Ortiz-Lopez; Mercedes Lobera; Jianfei Yang; Shomir Ghosh; Ashlee Earl; Scott B Snapper; Ray Jupp; Dennis Kasper; Diane Mathis; Christophe Benoist
Journal:  Science       Date:  2015-08-13       Impact factor: 47.728

2.  Endocrine self and gut non-self intersect in the pancreatic lymph nodes.

Authors:  Shannon J Turley; Je-Wook Lee; Nick Dutton-Swain; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-29       Impact factor: 11.205

3.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

4.  Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells.

Authors:  Angela M Thornton; Patricia E Korty; Dat Q Tran; Elizabeth A Wohlfert; Patrick E Murray; Yasmine Belkaid; Ethan M Shevach
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

5.  Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals With Long-standing Type 1 Diabetes.

Authors:  Jennie H M Yang; Antony J Cutler; Ricardo C Ferreira; James L Reading; Nicholas J Cooper; Chris Wallace; Pamela Clarke; Deborah J Smyth; Christopher S Boyce; Guo-Jian Gao; John A Todd; Linda S Wicker; Timothy I M Tree
Journal:  Diabetes       Date:  2015-07-29       Impact factor: 9.461

6.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

7.  Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate.

Authors:  Ye Zheng; Steven Josefowicz; Ashutosh Chaudhry; Xiao P Peng; Katherine Forbush; Alexander Y Rudensky
Journal:  Nature       Date:  2010-01-13       Impact factor: 49.962

8.  Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo.

Authors:  Mahesh Yadav; Cedric Louvet; Dan Davini; James M Gardner; Marc Martinez-Llordella; Samantha Bailey-Bucktrout; Bryan A Anthony; Francis M Sverdrup; Richard Head; Daniel J Kuster; Peter Ruminski; David Weiss; David Von Schack; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2012-09-10       Impact factor: 14.307

9.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.

Authors:  Nicholas Arpaia; Clarissa Campbell; Xiying Fan; Stanislav Dikiy; Joris van der Veeken; Paul deRoos; Hui Liu; Justin R Cross; Klaus Pfeffer; Paul J Coffer; Alexander Y Rudensky
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

View more
  12 in total

Review 1.  In search of lost time: Enhancers as modulators of timing in lymphocyte development and differentiation.

Authors:  Jonathan M Chu; Nicholas A Pease; Hao Yuan Kueh
Journal:  Immunol Rev       Date:  2021-03-18       Impact factor: 12.988

Review 2.  Activation pathways that drive CD4+ T cells to break tolerance in autoimmune diseases.

Authors:  Sai Harsha Krovi; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2022-02-10       Impact factor: 10.983

Review 3.  Function, Failure, and the Future Potential of Tregs in Type 1 Diabetes.

Authors:  Maria Bettini; Matthew L Bettini
Journal:  Diabetes       Date:  2021-05-20       Impact factor: 9.337

4.  Pancreatic autoantibodies and CD14+CD16+ monocytes subset are associated with the impairment of ß-cell function after simultaneous pancreas-kidney transplantation.

Authors:  Cristian Rodelo-Haad; Maria Luisa Agüera; Andres Carmona; Maria Dolores Navarro; Julia Carracedo; Alberto Rodriguez-Benot; Pedro Aljama
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

5.  Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model.

Authors:  Daniel R Holohan; Frédéric Van Gool; Jeffrey A Bluestone
Journal:  PLoS One       Date:  2019-10-24       Impact factor: 3.240

6.  Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes.

Authors:  Erica P Cai; Yuki Ishikawa; Wei Zhang; Nayara C Leite; Jian Li; Shurong Hou; Badr Kiaf; Jennifer Hollister-Lock; Nese Kurt Yilmaz; Celia A Schiffer; Douglas A Melton; Stephan Kissler; Peng Yi
Journal:  Nat Metab       Date:  2020-07-27

Review 7.  Nature vs. nurture: FOXP3, genetics, and tissue environment shape Treg function.

Authors:  Arielle Raugh; Denise Allard; Maria Bettini
Journal:  Front Immunol       Date:  2022-08-12       Impact factor: 8.786

8.  A Novel Tolerogenic Antibody Targeting Disulfide-Modified Autoantigen Effectively Prevents Type 1 Diabetes in NOD Mice.

Authors:  Wei Li; Yan Zhang; Ronghui Li; Yang Wang; Lan Chen; Shaodong Dai
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

9.  Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes.

Authors:  Neenu Jacob; Shivani Jaiswal; Deep Maheshwari; Nayudu Nallabelli; Neeraj Khatri; Alka Bhatia; Amanjit Bal; Vivek Malik; Savita Verma; Rakesh Kumar; Naresh Sachdeva
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

Review 10.  Two to Tango: Dialogue between Adaptive and Innate Immunity in Type 1 Diabetes.

Authors:  Lin Sun; Shugang Xi; Guangyu He; Zhuo Li; Xiaokun Gang; Chenglin Sun; Weiying Guo; Guixia Wang
Journal:  J Diabetes Res       Date:  2020-07-30       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.